XX, the U.S. Navy’s 6th-gen fighter, reveals it is being designed to solve the F-35C’s critical “range deficit.” -China’s ...
According to reporting from Reuters, reviewers at the agency pointed to an inability to differentiate from placebo to justify rejecting the drug, but an FDA office director approved the drug anyway.
Despite being plagued by a rash of disasters and safety concerns over the past several years, Boeing was awarded the F-47 ...
Neok Bio has exited stealth with $75 million to take a pair of bispecific antibody-drug conjugates sourced from ABL Bio into ...